However, our data show that ligand treatments and LXR activation in pancreatic cancer cells was solely anti-proliferative, and lacked the ability to induce apoptosis as measured by caspase-3 cleavage (Figure S5). The gene discussed is CASP3; the disease is familial pancreatic carcinoma.